Investment consortium to buy Syneos Health in $7.1 billion deal May 10, 2023 by True Academy Comments are off
Trulieve Cannabis misses revenue estimates on weak demand May 10, 2023 by True Academy Comments are off
HSBC maintains Vinaship at 'buy' with a price target of EUR38.00 May 10, 2023 by True Academy Comments are off
HSBC maintains Carl Zeiss Meditec at 'buy' with a price target of EUR128.00 May 10, 2023 by True Academy Comments are off
Israel hits targets in Gaza as Palestinians fire rockets across border May 10, 2023 by True Academy Comments are off
HSBC maintains KakaoBank at 'reduce' with a price target of KRW18000.00 May 10, 2023 by True Academy Comments are off
Bayer and Bicycle Therapeutics Enter Strategic Collaboration for Development of Novel Targeted Radionuclide Therapies in Oncology May 10, 2023 by True Academy Comments are off
HSBC maintains Grape King Bio at 'buy' with a price target of NT$220.00 May 10, 2023 by True Academy Comments are off
Teva ADR earnings missed by $0.15, revenue topped estimates May 10, 2023 by True Academy Comments are off
Decoding the Fed's Decision and Jobs Report: What's Next? May 10, 2023 by True Academy Comments are off
U.S. Debt Ceiling Talks in Focus, but CPI Data Could Have Bigger Impact on Markets May 10, 2023 by True Academy Comments are off
De-Dollarization Story Continues to Simmer, but Not Boil Over May 10, 2023 by True Academy Comments are off
U.S. Inflation Report Awaited for Direction as Stocks, Dollar Drift May 10, 2023 by True Academy Comments are off
Tempur Sealy Declares $0.11 Quarterly Dividend; 1.2% Yield May 9, 2023 by True Academy Comments are off
Voyager Therapeutics Appoints George Scangos to its Board May 9, 2023 by True Academy Comments are off
RBC Capital maintains Pennant Group at 'outperform' with a price target of $14.00 May 9, 2023 by True Academy Comments are off
Spotify reportedly deletes thousands of AI-generated songs May 9, 2023 by True Academy Comments are off
RBC Capital maintains Taskus at 'outperform' with a price target of $21.00 May 9, 2023 by True Academy Comments are off
RBC Capital maintains Viracta Therapeutics at 'outperform' with a price target of $7.00 May 9, 2023 by True Academy Comments are off
MultiPlan Corp. Acquires Leading Healthcare Data and Analytics Firm Benefits Science LLC May 9, 2023 by True Academy Comments are off
Rocket Pharmaceuticals Announces FDA Clearance of IND for Clinical Trial of RP-A601 May 9, 2023 by True Academy Comments are off
Seres Therapeutics Reports SER-155 Phase 1b Cohort 1 Results Showing Successful Drug Bacteria Engraftment and Substantial Reduction in Pathogen Domination May 9, 2023 by True Academy Comments are off
